国际麻醉学与复苏杂志   2022, Issue (2): 0-0
    
不同剂量艾司氯胺酮滴鼻用于学龄前患儿术前镇静抗焦虑效果比较
汲玮, 胡洁, 李禹, 黄悦1()
1.上海交大医学院附属儿童医学中心
Comparison of different doses of intranasal esketamine for reducing preoperative anxiety in preschool children
 全文:
摘要:

目的 观察不同剂量的艾司氯胺酮滴鼻用于学龄前患儿术前镇静抗焦虑的有效性及安全性。 方法 选择90例择期行先天性心脏病介入封堵术的2~6岁患儿,采用随机数字表法将患儿分为艾司氯胺酮0.5 mg/kg组(S1组)、艾司氯胺酮1.0 mg/kg组(S2组)、艾司氯胺酮1.5 mg/kg组(S3组),每组30例。在病房内给予患儿相应剂量的艾司氯胺酮滴鼻,30 min后转运至手术室。用简化版改良耶鲁术前焦虑评分(modified Yale Preoperative Anxiety Scale‑Short Form, mYPAS‑SF)量表评估患儿在艾司氯胺酮滴鼻前(T0)、艾司氯胺酮滴鼻后15 min(T1)、艾司氯胺酮滴鼻后30 min(T2)的焦虑水平,同时记录患儿心率、MAP、SpO2。用相应量表(Ramsay镇静评分、分离情绪评分、面罩配合评分)评估患儿与父母分离时的镇静水平、分离情绪满意情况、面罩配合满意情况,并记录术后24 h内不良反应发生情况。 结果 与S1组比较,S2组和S3组患儿T1及T2时mYPAS‑SF降低(P<0.05);与T0比较,3组患儿T1、T2时mYPAS‑SF均降低(P<0.05);与T1比较,3组患儿T2时mYPAS‑SF均升高(P<0.05);3组患儿T0时mYPAS‑SF差异无统计学意义(P>0.05);S2组与S3组患儿各时点mYPAS‑SF差异无统计学意义(P>0.05)。S2组、S3组患儿与父母的分离情绪满意率、面罩配合满意率均高于S1组(P<0.05)。3组患儿的镇静成功率差异无统计学意义(P>0.05)。S3组患儿术后恶心呕吐、烦躁的发生率高于S1组、S2组,但差异无统计学意义(P>0.05)。 结论 艾司氯胺酮1.0 mg/kg滴鼻可减轻学龄前患儿术前焦虑,与1.5 mg/kg剂量滴鼻同等有效,但降低了术后不良反应的发生率。

关键词: 艾司氯胺酮; 滴鼻; 焦虑; 镇静; 学龄前; 小儿
Abstract:

Objective To investigate the effectiveness and safety of different doses of intranasal esketamine for reducing preoperative anxiety in preschool children. Methods A total of 90 children, aged 2 to 6 years old, who were scheduled for interventional cardiac catheterisation were included in the current study. According to the random number table method, they were divided into three groups (n=3): an esketamine 0.5 mg/kg group (group S1), an esketamine 1.0 mg/kg group (group S2) and an esketamine 1.5 mg/kg group (group S3). The children were administered with the corresponding dosage of intranasal esketamine in the ward, and then transferred to the operating room 30 min later. The modified Yale Preoperative Anxiety Scale⁃Short Form (mYPAS⁃SF) was used to evaluate children's anxiety at the following time points: before nasal drip (T0), 15 min after nasal drip (T1), and 30 min after nasal drip (T2). Meanwhile, the heart rate, mean artery pressure (MAP) and oxygen saturation (SpO2) were recorded. The level of sedation, the satisfaction of separation emotion and the satisfaction of mask cooperation were evaluated using the corresponding scales (Ramsay scores, ease of separation and ease of induction score), and the incidence of adverse reactions within 24 h after operation was recorded. Results Compared with group S1, the mYPAS⁃SF of group S2 and group S3 at T1 and T2 was reduced (P<0.05). Compared with T0, mYPAS‑SF decreased at T1 and T2 in the three groups (P<0.05). Compared with those at T1, mYPAS‑SF increased at T2 in the three groups (P<0.05). There was no significant difference in mYPAS⁃SF among the three groups at T0 (P>0.05). There was no significant difference in mYPAS⁃SF between group S2 and group S3 at each time point (P>0.05). The satisfaction rates of separation emotion and mask cooperation in both group S2 and group S3 were higher than those in group S1 (P<0.05). There was no significant difference in the success rate of sedation among the three groups (P>0.05). The incidences of postoperative nausea, vomiting and irritability in group S3 were higher than those in the other two groups, without statistical differences (P>0.05). Conclusions Intranasal esketamine at 1.0 mg/kg can relieve the preoperative anxiety of preschool children, which is equivalent to intranasal esketamine at 1.5 mg/kg but reduces the incidence of postoperative adverse reactions.

Key words: Esketamine; Intranasal; Anxiety; Sedative; Preschool; Children